Nihon Kohden has appointed Yasuhiro Yoshitake as its new president and CEO. Yoshitake is taking over the helm of the organization from Wilson P. Constantine, MD, who led the organization from April 2015 to February 2019.

Yoshitake’s appointment coincides with the realignment of US leadership, including the development of three new positions to optimize the organization for continued growth. The new positions—a chief operations officer, a chief financial officer, and a chief commercial officer—as well as the company’s chief technology officer, will report directly to Yoshitake.

“The US is a dynamic healthcare market that requires deep collaboration between the corporate headquarters in Japan and the U.S. organization,” says Hirokazu Ogino, president and CEO of Nihon Kohden Corp, in a release. “Yoshitake’s understanding of Nihon Kohden and deep experience around the world will allow us to continue to build our presence and facilitate growth in the United States.”

Yoshitake first joined Nihon Kohden in 1988. He has held key positions in multiple regions around the world, including Europe and China, as well as in Asia and Middle East operations. Most recently, he served as Nihon Kohden’s general manager of international operations and corporate director and operating officer, which are positions that he will retain as part of his new role.

As part of the realignment, several structural shifts have been made across the organization, including:

  • Harsh Dharwad will continue in his role as vice president and chief technology officer reporting to Yoshitake.
  • Scott Iserman has been promoted to chief commercial officer and will be responsible for the commercial strategy and for building a commercialization infrastructure and organization that drives business growth and market share.
  • Shinya Hama has been promoted to chief operations officer, responsible for effective operations of the business, including delivery of products and services, overall quality and utilization of resources to ensure efficiency.
  • Kenji Sakai joined the organization as chief financial officer, responsible for identifying and evaluating new business opportunities to funnel our growth, providing financial direction on larger more complex transactions, and providing leadership to the finance department.

“The American healthcare market is a significant part of Nihon Kohden’s future,” Yoshitake says. “We believe these shifts will allow us to continue building upon the significant growth Nihon Kohden has secured in the last few years and position us to achieve our goal of further growing our share of the market.”